tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Kim, 7 are a BUY (100%).
Analyst Sean Kim, currently employed at JONESTRADING, carries an average stock price target met ratio of 50% that have a potential upside of 185.2% achieved within 311 days.
Sean Kim’s has documented 14 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EYPT, Eyepoint Pharmaceuticals at 04-Dec-2023.
Analyst best performing recommendations are on EYPT (EYEPOINT PHARMACEUTICALS).
The best stock recommendation documented was for EYPT (EYEPOINT PHARMACEUTICALS) at 6/14/2023. The price target of $26 was fulfilled within 226 days with a profit of $18.97 (269.84%) receiving and performance score of 11.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Feb-2020
$38
$12.84 (51.03%)
$35
1 months 28 days ago
(06-Aug-2026)
1/3 (33.33%)
$11.57 (43.78%)
27
Buy Since 20-Nov-2021
$38
$12.84 (51.03%)
$18
1 months 28 days ago
(06-Aug-2026)
3/11 (27.27%)
$11.57 (43.78%)
252
Buy Since 07-Sep-2022
$40
$14.84 (58.98%)
$36
1 months 28 days ago
(06-Aug-2026)
19/25 (76%)
$13.57 (51.34%)
443
Buy Since 23-Feb-2024
$35
$8 (29.63%)
$37
7 months 2 days ago
(02-Mar-2026)
9/27 (33.33%)
$10.24 (41.36%)
345
Buy Since 07-Aug-2025
$35
$8 (29.63%)
$30
7 months 8 days ago
(26-Feb-2026)
2/3 (66.67%)
$6.43 (22.51%)
55
What Year was the first public recommendation made by Sean Kim?
